porcin
epidem
diarrhea
viru
pedv
member
genu
alphacoronaviru
caus
agent
porcin
enter
diseas
character
acut
wateri
diarrhea
dehydr
suck
piglet
similar
coronavirus
pedv
spike
protein
mediat
cell
entri
bind
cellular
receptor
induc
membran
fusion
viral
envelop
cellular
membran
howev
entri
mechan
pedv
studi
determin
entri
mechan
pedv
vero
cell
data
confirm
pedv
entri
follow
clathrinmedi
endocytosi
independ
caveolaeco
pit
assembl
intern
pedv
coloc
clathrinmedi
endocyt
marker
caveolaemedi
endocyt
marker
addit
cell
treat
lysosomotrop
agent
serin
proteas
inhibitor
resist
pedv
data
reveal
pedv
entri
follow
clathrinmedi
endocytosi
depend
low
ph
serin
proteolysi
success
entri
cell
infect
envelop
virus
initi
bind
surfac
protein
specif
receptor
surfac
cell
membran
lead
intern
viru
cell
second
step
infect
follow
viru
attach
uncoat
viral
genom
cytoplasm
viral
envelop
fuse
host
membran
two
major
rout
envelop
virus
enter
host
cell
nonendosom
endosom
pathway
pelkman
heleniu
smith
heleniu
pathway
requir
releas
viral
genom
fusion
viral
envelop
respect
target
membran
host
cell
plasma
endosom
membran
respect
matlin
et
al
nonendosom
pathway
viral
envelop
directli
fuse
plasma
membran
membran
fusion
mediat
conform
chang
viral
glycoprotein
induc
interact
correspond
receptor
host
cell
surfac
andor
proteolyt
process
blumenth
et
al
endocyt
pathway
differenti
two
wellcharacter
pathway
act
via
clathrinco
pit
caveolaemedi
lipid
raft
brodski
et
al
pelkman
heleniu
intern
virus
requir
lowph
environ
endosom
trigger
conform
chang
viral
glycoprotein
acid
ph
environ
also
import
proteolyt
activ
viral
glycoprotein
endosom
proteas
qiu
et
al
simmon
et
al
porcin
epidem
diarrhea
viru
pedv
classifi
alphacoronaviru
togeth
transmiss
gastroenter
viru
tgev
felin
infecti
periton
viru
fipv
human
coronaviru
pedv
caus
acut
wateri
diarrhea
suckl
piglet
result
approxim
mortal
among
suckl
piglet
reduc
weight
among
fatten
pig
debouck
pensaert
porcin
epidem
diarrhea
ped
first
recogn
pig
unit
kingdom
wood
although
evid
ped
current
report
canada
similar
coronaviruslik
particl
report
herd
quebec
turgeon
et
al
sinc
outbreak
ped
document
mani
european
asian
countri
czech
republ
hungari
korea
philippin
china
itali
thailand
germani
spain
japan
song
park
recent
pedv
spread
rapidli
swine
farm
unit
state
result
high
mortal
piglet
state
mole
typic
alphacoronaviru
pedv
spike
protein
encount
viru
entri
host
cell
interact
receptor
porcin
aminopeptidas
n
apn
porcin
enterocyt
mediat
membran
fusion
host
cell
membran
li
et
al
oh
et
al
upon
receptor
bind
sever
coronavirus
alphacoronaviru
enter
cell
via
endocytosi
exampl
extens
studi
shown
upon
bind
human
apn
receptor
taken
lipid
raft
enter
via
caveolaedepend
endocytosi
nomura
et
al
insid
endosom
cellular
proteas
activ
lowph
environ
facilit
membran
fusion
kawas
et
al
similarli
tgev
bind
porcin
apn
weingartl
derbyshir
shown
enter
mdck
cell
overexpress
porcin
apn
via
endocytosi
acidif
intracellular
compart
facilit
membran
fusion
hansen
et
al
fipv
also
requir
acidif
endosom
success
entri
takano
et
al
inhibit
fipv
infect
nystatin
pharmacolog
reagent
caus
caveola
flatten
disrupt
coat
structur
dynamin
inhibitor
suggest
fipv
entri
might
actual
involv
type
caveolaedepend
endocytosi
van
hamm
et
al
although
sever
studi
examin
mechan
entri
coronavirus
mechan
pedv
entri
still
unknown
studi
studi
entri
mechan
pedv
measur
viru
infect
presenc
chemic
inhibitor
coloc
pedv
endocyt
pathway
marker
found
pedv
infect
diminish
treatment
chloropromazin
cpz
lysosomotrop
agent
addit
also
investig
pedv
requir
serinelik
proteas
entri
endocytosi
cellcel
fusion
taken
togeth
find
reveal
pedv
enter
vero
cell
via
clathrinmedi
endocytosi
requir
serin
proteolysi
infect
vero
cell
maintain
eagl
minimum
essenti
medium
mem
gibco
contain
heatinactiv
fetal
bovin
serum
fb
gibco
uml
penicillin
gml
streptomycin
gml
amphotericin
b
vero
celladapt
korean
strain
propag
vero
cell
describ
previous
hofmann
wyler
briefli
vero
cell
inocul
multipl
infect
moi
cultur
serumfre
mem
h
c
co
progeni
virus
titrat
use
focu
format
assay
follow
method
describ
previous
cruz
shin
infect
vero
cell
trypsin
nontrypsin
condit
compar
h
vero
cell
tissu
cultur
tc
plate
spl
labwar
inocul
cultur
either
serumfre
mem
mem
supplement
trypsin
gml
infect
stop
addit
paraformaldehyd
pfa
indic
time
immunocytochemistri
vero
cell
treat
variou
concentr
either
cpz
min
sucros
min
inhibit
format
clathrinco
pit
block
caveolaedepend
pathway
cell
incub
variou
concentr
nystatin
min
control
cell
incub
without
dimethyl
sulfoxid
dmso
cell
inocul
moi
h
overlaid
methyl
cellulos
mem
contain
trypsin
h
hpi
pedvinfect
cell
detect
immunocytochemistri
prepar
ultrapurifi
trypsinfre
virus
vero
cell
inocul
moi
cultur
serumfre
mem
h
supernat
clarifi
centrifug
g
min
c
follow
ultracentrifug
use
sucros
cushion
g
h
follow
resuspens
buffer
tri
ph
nacl
cacl
protein
concentr
purifi
viru
stock
determin
bradford
assay
fluorochrom
conjug
alexa
fluor
carboxyl
acidsuccinimidyl
ester
molecular
probe
perform
accord
manufactur
instruct
briefli
mg
ultrapurifi
dialyz
label
buffer
nahco
ph
c
overnight
viru
incub
h
platform
rocker
room
temperatur
g
succinimidyl
ester
l
dmso
extens
dialyz
buffer
vero
cell
prepar
cover
glass
day
assay
coloc
endocyt
marker
cell
incub
combin
gml
alexa
fluor
transferrin
gml
alexa
fluor
toxin
subunit
b
min
ice
synchron
entri
shift
c
unbound
virus
remov
cell
fix
pfa
indic
time
analyz
magnif
laser
scan
confoc
microscop
vero
cell
treat
either
mm
nh
cl
gml
neutral
intracellular
ph
cell
inocul
moi
h
presenc
lysosomotrop
agent
viru
inoculum
remov
wash
pb
cell
overlaid
methyl
cellulos
mem
contain
trypsin
h
hpi
pedvinfect
cell
detect
immunocytochemistri
effect
low
ph
fusion
activ
protein
investig
subject
pedvinfect
vero
cell
low
ph
rang
vero
cell
inocul
cultur
trypsinfre
mem
h
afterward
cell
monolay
wash
thrice
pb
replenish
serumfre
mem
adjust
ph
mem
contain
trypsin
gml
ph
use
posit
control
cultur
incub
c
h
fix
pfa
pedvinfect
cell
detect
immunocytochemistri
cell
pretreat
variou
proteas
inhibitor
aebsfhcl
pepstatin
gml
phosphoramidon
h
examin
synergist
antivir
activ
aebsfhcl
lysosomotrop
agent
cell
treat
aebsfhcl
andor
nh
cl
h
treat
cell
infect
moi
h
presenc
inhibitor
h
adsorpt
viru
inoculum
remov
wash
pb
cell
overlaid
methyl
cellulos
mem
contain
trypsin
h
hpi
pedvinfect
cell
detect
immunocytochemistri
vero
cell
pretreat
either
mm
nh
cl
gml
cpz
inocul
moi
h
adsorpt
viru
inoculum
remov
wash
pb
cell
overlaid
methyl
cellulos
mem
contain
trypsin
h
hpi
pedvinfect
cell
detect
immunocytochemistri
detect
express
viral
protein
infect
vero
cell
fix
pfa
min
permeabil
follow
three
wash
pb
cell
incub
dilut
mous
antipedv
polyclon
antibodi
h
cell
wash
three
time
pb
incub
dilut
goat
antimous
igg
conjug
horseradish
peroxidas
infect
vero
cell
stain
use
diaminobenzidin
tetrahydrochlorid
solut
contain
nicl
h
vector
laboratori
cluster
immunostain
cell
observ
invert
microscop
zeiss
present
ratio
mocktreat
dmso
treat
cell
vero
cell
prepar
tc
plate
treat
variou
chemic
inhibit
endocyt
pathway
describ
cell
inocul
moi
presenc
drug
hpi
unbound
virus
wash
cell
incub
serumfre
mem
infect
cell
harvest
lyse
proprep
protein
extract
solut
intron
hpi
extract
protein
dilut
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
sampl
buffer
electrophores
sdspage
system
separ
protein
electr
transfer
onto
polyvinyl
difluorid
membran
pedv
n
protein
trace
use
antipedv
polyclon
antibodi
band
visual
use
supersign
west
dura
report
pedv
requir
extracellular
trypsin
success
infect
vitro
kusanagi
et
al
lai
cavanagh
park
et
al
earli
data
infect
pedv
first
provid
hofmann
wyler
demonstr
format
multinucl
cell
pedvinfect
vero
cell
supplement
cultur
media
trypsin
hofmann
wyler
trypsininduc
syncytium
format
corrobor
li
et
al
papnexpress
mdck
cell
infect
pedv
presenc
trypsin
li
et
al
previou
find
suggest
proteolyt
process
protein
requir
facilit
viral
membran
fusion
cellular
membran
also
rais
possibl
pedv
entri
direct
fusion
plasma
membran
could
take
place
presenc
trypsin
confirm
role
exogen
proteas
pedv
infect
pedv
infect
cell
treat
trypsin
evalu
viral
infect
immunocytochemistri
shown
fig
found
pedv
could
infect
vero
cell
even
without
trypsin
treatment
initi
infect
confirm
earli
hpi
trypsin
nontrypsin
condit
number
infect
cell
condit
similar
spread
adjac
cell
faster
presenc
trypsin
hpi
cell
monolay
form
larg
multinucl
cell
sharp
contrast
pedv
growth
without
exogen
trypsin
involv
syncyti
spread
hpi
cell
show
sign
infect
still
cytopath
effect
cpe
found
result
confirm
trypsin
catalyz
pedv
proteinmedi
cellcel
fusion
demonstr
previous
hofmann
wyler
park
et
al
base
observ
conclud
exogen
proteas
like
trypsin
necessari
induc
cellcel
fusion
pedvinfect
vero
cell
essenti
requir
viruscel
entri
hypothes
pedv
entri
vero
cell
trypsinfre
condit
like
occur
insid
endosom
compart
cellular
proteas
might
oper
similar
trypsin
facilit
smediat
fusion
pedv
endosom
membran
envelop
viru
entri
endocytosi
differenti
two
wellcharacter
pathway
act
via
clathrinco
pit
caveolaemedi
lipid
raft
brodski
et
al
pelkman
heleniu
explor
whether
endocyt
pathway
support
pedv
entri
vero
cell
endocyt
pathway
alter
pedv
infect
inhibit
pathway
use
substanc
interf
either
clathrinmedi
endocytosi
caveolaemedi
endocytosi
inhibit
clathrinmedi
endocytosi
use
either
cpz
known
abolish
format
clathrinco
vesicl
interf
interact
adapt
protein
clathrinco
pit
lattic
thu
inhibit
clathrindepend
endocytosi
ii
hyperton
sucros
inhibit
clathrinmedi
endocytosi
induc
dispers
clathrin
lattic
plasma
membran
inhibit
caveolaemedi
endocytosi
use
nystatin
polyen
antifung
agent
interact
cholesterol
inhibit
lipid
raftcaveolin
pathway
concentr
substanc
chosen
accord
previou
studi
show
inhibit
envelop
virus
enter
cell
via
thee
endocyt
pathway
access
inhibitori
effect
cpz
pedv
infect
vero
cell
treat
cpz
infect
measur
inhibitori
effect
viru
entri
cell
overlaid
methyl
cellulos
mem
contain
trypsin
h
media
contain
methyl
cellulos
trypsin
block
secondcycl
infect
allow
format
syncytium
visual
infect
cell
infect
determin
measur
infect
cell
immunocytochemistri
stain
hpi
normal
untreat
cell
control
shown
fig
pedv
infect
remark
diminish
cpz
treatment
inhibit
rate
posit
relat
concentr
cpz
confirm
decreas
replic
pedv
determin
express
pedv
nucleocapsid
n
protein
western
blot
pedv
n
protein
far
less
express
cpztreat
cell
compar
untreat
cell
fig
wherea
express
consist
previou
result
pedv
infect
hyperton
sucros
treat
also
significantli
inhibit
fig
result
strongli
suggest
pedv
use
clathrinmedi
endocytosi
pathway
entri
vero
cell
similar
experi
perform
nystatin
treatment
determin
whether
pedv
also
use
caveolaemedi
endocytosi
unlik
cpz
treatment
pedv
infect
slightli
decreas
highest
concentr
fig
likewis
level
pedv
n
protein
synthes
virtual
ident
presenc
absenc
nystatin
fig
verifi
confirm
result
sever
marker
specif
clathrinmedi
pathway
caveolaemedi
endocytosi
use
provid
direct
evid
pedv
use
pathway
entri
trace
visual
pedv
locat
vero
tf
transport
cell
vesicl
receptormedi
clathrindepend
endocytosi
pathway
ctb
specif
bind
glycolipid
monogangliosid
plasma
membran
intern
deliv
golgi
complex
caveolaemedi
endocytosi
pathway
nichol
vero
cell
incub
fluorescencelabel
pedv
along
marker
evalu
subcellular
local
confoc
microscopi
h
later
endocyt
marker
ctb
tf
locat
cytoplasm
coloc
observ
pedv
tf
fig
ctb
fig
confirm
find
vero
cell
treat
cpz
nystatin
prior
pedv
inocul
shown
fig
pedv
tf
coloc
cytoplasm
nystatin
mocktreat
cpztreat
vero
cell
pedv
tf
found
cell
surfac
indic
clathrinmedi
tf
green
ctb
green
b
observ
merg
imag
c
coloc
yellow
tf
observ
insid
cell
mockand
nystatintr
vero
cell
contrast
cpz
treatment
inhibit
intern
tf
interpret
refer
color
figur
legend
reader
refer
web
version
articl
endocytosi
success
complet
inhibit
cpz
treatment
taken
togeth
confirm
conclud
clathrinmedi
endocytosi
pathway
import
pedv
entri
next
explor
whether
pedv
infect
requir
acid
environ
endosom
compart
inhibit
endosom
acidif
vero
cell
treat
either
nh
cl
rel
weak
base
accumul
insid
endosom
vesicl
specif
inhibitor
vacuolar
hatpas
anim
eukaryot
cell
neutral
ph
acid
organel
confirm
fluoresc
ph
indic
probe
lysosensor
data
shown
evalu
inhibitori
activ
differ
lysosomotrop
reagent
measur
infect
cell
lysosomotrop
reagent
show
strong
inhibitori
effect
product
progeni
pedv
especi
reduct
hpi
output
titer
nh
cl
fig
pedv
replic
inhibit
concentr
low
nm
result
indic
pedv
entri
sensit
low
ph
acid
condit
endosom
andor
late
endosom
might
critic
entri
observ
whether
acidif
sole
induc
pedv
smediat
fusion
evalu
pedv
smediat
cellcel
fusion
acid
condit
shown
fig
low
ph
induc
cellcel
fusion
syncytium
format
observ
cell
condit
ph
ph
panel
ad
similarli
syncytium
format
found
neutral
ph
condit
panel
e
stark
contrast
cellcel
fusion
observ
addit
trypsin
cultur
media
neutral
ph
panel
f
collect
conclud
acid
condit
import
still
suffici
pedv
smediat
membran
fusion
also
fusogen
properti
protein
could
activ
proteolyt
process
evalu
role
effect
proteas
trypsin
pedv
entri
use
proteas
inhibitor
first
check
cytotox
inhibitor
exclud
fals
result
recommend
concentr
confirm
cell
damag
data
shown
shown
fig
found
aebsfhcl
induc
strongest
inhibitori
activ
inhibit
contrast
pepstatin
phosphoramidon
show
rel
lower
inhibit
inhibit
result
suggest
serin
proteas
importantli
involv
pedv
entri
vero
cell
case
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
report
phdepend
endosom
cellular
factor
requir
proteolyt
activ
protein
rather
viru
requir
acid
trigger
qiu
et
al
simmon
et
al
evalu
pedv
case
cell
treat
aebsfhcl
combin
prior
infect
shown
previou
result
pedv
infect
significantli
inhibit
either
aebsfhcl
nh
cl
treatment
fig
inhibitori
effect
combin
treatment
similar
aebsfhcl
singl
treatment
protein
activ
exogen
proteas
render
coronaviru
mediat
viruscel
fusion
independ
cathepsin
activ
final
determin
whether
trypsin
treatment
bypass
entri
inhibit
endocytosi
inhibitor
vero
cell
pretreat
either
cpz
gml
min
nh
cl
mm
h
prior
viru
infect
infect
pedv
absenc
presenc
trypsin
pedv
infect
slightli
facilit
trypsin
treatment
trypsin
treatment
overcom
inhibitori
effect
nh
cl
cpz
small
increas
pedv
infect
might
obtain
rapid
spread
viru
infect
via
cellcel
fusion
result
suggest
trypsin
support
proteasesmedi
viruscel
entri
entri
mechan
pedv
coronaviru
larg
unknown
examin
entri
pathway
pedv
vero
cell
use
essenti
two
independ
complementari
approach
focu
format
assay
assess
level
infect
virus
cell
treat
variou
inhibitor
ii
fluoresc
microscopi
monitor
entri
virus
cell
along
wellestablish
marker
approach
provid
similar
conclus
mechan
pedv
cell
entri
infect
inhibit
assay
use
variou
substrat
interfer
endocytosi
lysosomotrop
agent
reveal
pedv
enter
vero
cell
via
clathrinmedi
endocyt
uptak
deliveri
viru
acid
intracellular
compart
interestingli
found
pedv
requir
serin
proteolyt
process
earli
stage
infect
serin
proteolysi
activ
pedv
entri
independ
manner
acid
ph
environ
bypass
infect
reduct
lysosomotrop
agent
cell
entri
mani
coronavirus
proteolyt
activ
protein
trigger
viral
membran
fusion
essenti
requir
viru
entri
huang
et
al
qiu
et
al
simmon
et
al
cathepsin
famili
cystein
proteinas
commonli
found
acidifi
endosom
associ
proteolyt
process
glycoprotein
sarscov
mediat
viral
membran
fusion
endosom
membran
within
endosom
kawas
et
al
qiu
et
al
regan
et
al
simmon
et
al
turk
et
al
similarli
variou
exogen
cellular
proteas
trypsin
transmembran
proteas
serin
enhanc
sarscov
entri
induc
viruscel
fusion
cell
surfac
glowacka
et
al
matsuyama
et
al
matsuyama
et
al
shulla
et
al
block
infect
mediat
lysosomotrop
agent
could
bypass
treat
exogen
cellular
proteas
matsuyama
et
al
simmon
et
al
pedv
infect
vitro
also
larg
depend
trypsin
supplement
hofmann
wyler
park
et
al
rais
possibl
pedv
could
fuse
plasma
membran
activ
proteas
deliv
genom
cell
howev
studi
demonstr
pedv
entri
occur
without
exogen
proteas
although
pedv
infect
like
facilit
trypsin
treatment
demonstr
earlier
pedv
also
propag
even
without
trypsin
fig
base
result
could
confirm
exogen
proteas
especi
trypsin
might
critic
factor
cellcel
fusion
viral
envelopecel
membran
fusion
also
could
conclud
trypsin
essenti
requir
viru
entri
vero
cell
result
encourag
us
hypothes
pedv
penetr
must
facilit
fusion
envelop
host
membran
fusionpermiss
environ
like
occur
insid
endosom
compart
pedv
might
take
endosom
entri
pathway
rather
direct
fusion
experi
use
variou
inhibitor
support
hypothesi
pedv
alter
endosom
pathway
entri
pedv
infect
greatli
diminish
pretreat
cpz
hypoton
sucros
fig
suggest
pedv
enter
vero
cell
via
clathrinmedi
pathway
furthermor
coloc
endocytos
tf
fluorochromelabel
pedv
may
support
conclus
clathrin
mediat
endocyt
uptak
major
pathway
entri
fig
data
collect
propos
pedv
enter
vero
cell
via
clathrinmedi
endocytosi
similar
coronavirus
vero
cell
treat
lysosomotrop
agent
either
infect
pedv
entri
score
immunocytochemistri
hpi
rel
infect
show
percentag
infect
cell
untreat
cell
error
bar
repres
standard
deviat
mean
valu
b
low
ph
convert
pedv
protein
fusogen
form
pedv
infect
vero
cell
expos
variou
ph
condit
incub
serumfre
media
h
low
neutral
ph
rang
ph
induc
cellcel
fusion
pedvinfect
vero
cell
contrast
addit
trypsin
neutral
ph
readili
induc
cellcel
fusion
within
h
treatment
lower
right
order
mediat
membran
fusion
envelop
virus
influenza
dengu
low
ph
acidifi
endosom
compart
suffici
conform
chang
plemper
unlik
virus
phdepend
endosom
cellular
factor
requir
activ
low
phdepend
proteas
rather
viru
requir
acid
trigger
huang
et
al
simmon
et
al
similar
coronavirus
pedv
infect
significantli
inhibit
nh
cl
fig
acid
ph
induc
pedv
smediat
fusion
fig
suggest
low
ph
differ
mediat
viru
fusion
anoth
trigger
factor
proteolyt
activ
might
requir
success
fusion
trypsin
induc
fusion
activ
pedv
protein
plasma
membran
demonstr
format
syncytia
fig
clear
whether
similar
condit
requir
fusion
envelop
endosom
membran
pedv
entri
vero
cell
specif
inhibit
serin
proteas
inhibitor
proteas
fig
suggest
serin
serinelik
proteas
cytoplasm
involv
facilit
fusion
pedv
envelop
host
endosom
membran
clear
serin
proteas
involv
pedv
entri
howev
assum
intracellular
serin
proteas
may
cleav
protein
induc
membran
fusion
infect
shown
fig
inhibitori
effect
serin
proteas
inhibitor
observ
lysosomotrop
reagent
treat
indic
novel
serin
proteas
involv
pedv
entri
acid
ph
independ
manner
unlik
low
phdepend
endosom
cathepsin
addit
find
trypsin
treatment
bypass
infect
inhibit
lysosomotrop
agent
cpz
shown
fig
clearli
indic
pedv
entri
requir
phdepend
step
rather
presenc
phdepend
proteolyt
process
recent
similar
possibl
propos
other
mediat
infect
studi
wicht
et
al
anoth
question
trypsin
suffici
mediat
cellcel
fusion
neutral
ph
report
furin
cleavag
mhv
sarscov
requir
viruscel
fusion
cellcel
fusion
de
haan
et
al
folli
et
al
seem
like
coronaviru
smediat
cellcel
fusion
regul
differ
manner
viruscel
fusion
acid
ph
serin
proteolysi
suffici
viruscel
fusion
contrast
serin
proteolysi
andor
unknown
factor
may
provid
similar
condit
low
ph
requir
cellcel
fusion
plasma
membran
thu
induc
membran
fusion
without
low
ph
data
confirm
pedv
entri
follow
clathrinmedi
endocytosi
independ
caveolaeco
pit
assembl
intern
pedv
coloc
clathrinmedi
endocyt
marker
caveolaemedi
endocyt
marker
addit
cell
treat
lysosomotrop
agent
serin
proteas
inhibitor
resist
pedv
data
reveal
pedv
entri
follow
clathrinmedi
endocytosi
depend
acid
ph
serin
proteolysi
success
entri
cell
